Skip to content

DMII - Drugs Made In America Acquisition II Corp. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchD

Drugs Made In America Acquisition II Corp. Ordinary Shares

DMII · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

D

DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $10.20
52-wk low: $9.86
Prev close: $9.64
Mkt cap: $644.6M
P/E: 34.9x
P/B: 1.3x

Smart money

6 funds hold a position.

Real smart money

Funds holding this stock

6 holders

Combined position$52.6M

MI
Millennium
Israel Englander · Q2 2026 13F
$20.1M
position
DS
D.E. Shaw
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

Reasonably priced and running thin margins.

Net margin: 0.0%
P/E: 34.90
Market cap: $645M

Valuation

P/B1.30

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: DMII
Exchange: NASDAQ
Sector: FINANCIAL SERVICES
Industry: SHELL COMPANIES
Market cap: $644.64M

Analysts

What do analysts expect?

No data yet

No analyst coverage yet for this stock.

We show it when enough analysts cover the stock.

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

+0.0%

$14.8M

position

TS

Two Sigma

Q2 2026 13F

$8.9M

position

3 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 3 holders

Coverage gaps for DMII

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

0.0%

ROA-0.3%

Growth